Using AsPC-1 cells in which GSDME was knocked out, we further demonstrated that only WT GSDME (not GSDME-D270A or WT GSDMB) rescued the GSDME-deficiency-retarded tumour growth in the pancreas (Fig. 4e). Here, GSDME is linked to neoplasm.